Financials

  • Market Capitalization 1.85 B
  • Employee 524
  • Founded 2008
  • CEO Bahija Jallal
  • Website www.immunocore.com
  • Headquarter United Kingdom
  • FIGI BBG00YYCXFB9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-48.89
Price to sales ratio
4.37

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2012
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
7.61 USD-0.91%-8.64%+15.30%+218.41%1.98 B USD
2017
NBTX
Nanobiotix S.A. - ADSs
40.58 USD-1.58%+1.45%+8.01%+389.51%1.96 B USD
2061
VIR
Vir Biotechnology, Inc. - Common Stock
10.75 USD-0.74%+8.37%+23.00%+79.77%1.82 B USD
2064
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.58 USD-3.29%-7.77%-5.26%+92.41%1.82 B USD

Frequently asked questions about Immunocore Holdings plc American Depositary Shares

What is the Immunocore Holdings plc American Depositary Shares stock price today?

The current price of Immunocore Holdings plc American Depositary Shares (IMCR) is 35.92. Over the past 24 hours, the stock has changed by -1.91%. Follow the IMCR chart for real-time price dynamics.

What is the stock ticker of Immunocore Holdings plc American Depositary Shares?

Immunocore Holdings plc American Depositary Shares trades under the ticker IMCR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Immunocore Holdings plc American Depositary Shares stock going up?

IMCR has changed by -2.13% over the last week, +6.27% over the last month, and +7.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Immunocore Holdings plc American Depositary Shares?

Immunocore Holdings plc American Depositary Shares currently has a market capitalization of 1.85 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Immunocore Holdings plc American Depositary Shares earnings last quarter?

Last quarter, Immunocore Holdings plc American Depositary Shares reported earnings of -0.02 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Immunocore Holdings plc American Depositary Shares revenue for the last quarter?

Immunocore Holdings plc American Depositary Shares reported quarterly revenue of 115.93 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Immunocore Holdings plc American Depositary Shares net income for the last quarter?

Immunocore Holdings plc American Depositary Shares reported net income of -808 K for the last quarter. The previous quarter showed 12.97 M, which means net income changed by -106.23%.

How many employees does Immunocore Holdings plc American Depositary Shares have?

As of the latest available data, Immunocore Holdings plc American Depositary Shares has 524 employees. Workforce size can provide additional context about the company's scale and operations.

What is Immunocore Holdings plc American Depositary Shares EBITDA?

Immunocore Holdings plc American Depositary Shares EBITDA is -1.97 M, and its EBITDA margin is -1.7%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Immunocore Holdings plc American Depositary Shares stock?

You can buy Immunocore Holdings plc American Depositary Shares (IMCR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Immunocore Holdings plc American Depositary Shares stock?

Investing in Immunocore Holdings plc American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMCR chart and related analysis on metatrader.com as part of your research.

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

News